233 related articles for article (PubMed ID: 33751995)
1. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
Skariyachan S; Gopal D; Muddebihalkar AG; Uttarkar A; Niranjan V
Comput Biol Med; 2021 May; 132():104325. PubMed ID: 33751995
[TBL] [Abstract][Full Text] [Related]
2. Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs.
Skariyachan S; Gopal D; Chakrabarti S; Kempanna P; Uttarkar A; Muddebihalkar AG; Niranjan V
Comput Biol Med; 2020 Nov; 126():104054. PubMed ID: 33074111
[TBL] [Abstract][Full Text] [Related]
3. Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studies.
Skariyachan S; Gopal D; Deshpande D; Joshi A; Uttarkar A; Niranjan V
Infect Genet Evol; 2021 Dec; 96():105155. PubMed ID: 34823028
[TBL] [Abstract][Full Text] [Related]
4. Response regulator GacA and transcriptional activator RhlR proteins involved in biofilm formation of Pseudomonas aeruginosa are prospective targets for natural lead molecules: Computational modelling, molecular docking and dynamic simulation studies.
Skariyachan S; Ravishankar R; Gopal D; Muddebihalkar AG; Uttarkar A; Praveen PKU; Niranjan V
Infect Genet Evol; 2020 Nov; 85():104448. PubMed ID: 32622078
[TBL] [Abstract][Full Text] [Related]
5. Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against
Gopal D; Muddebihalkar AG; Skariyachan S; C AU; Kaveramma P; Praveen U; Shankar RR; Venkatesan T; Niranjan V
J Biomol Struct Dyn; 2020 Sep; 38(15):4584-4599. PubMed ID: 31625462
[No Abstract] [Full Text] [Related]
6. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
Rana S; Skariyachan S; Uttarkar A; Niranjan V
Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
[TBL] [Abstract][Full Text] [Related]
7. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
[TBL] [Abstract][Full Text] [Related]
8. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
9.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
10. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant
Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V
J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742
[TBL] [Abstract][Full Text] [Related]
11. Computational design of prospective molecular targets for Burkholderia cepacia complex by molecular docking and dynamic simulation studies.
Skariyachan S; Praveen PKU; Uttarkar A; Niranjan V
Proteins; 2023 Jun; 91(6):724-738. PubMed ID: 36601892
[TBL] [Abstract][Full Text] [Related]
12. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
Prasanth DSNBK; Murahari M; Chandramohan V; Guntupalli C; Atmakuri LR
J Biomol Struct Dyn; 2022; 40(22):11822-11836. PubMed ID: 34396938
[TBL] [Abstract][Full Text] [Related]
13. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
Dhameliya TM; Nagar PR; Gajjar ND
Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
[TBL] [Abstract][Full Text] [Related]
14. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
15. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM
Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152
[TBL] [Abstract][Full Text] [Related]
17. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
Achutha AS; Pushpa VL; Suchitra S
J Proteome Res; 2020 Nov; 19(11):4706-4717. PubMed ID: 32960061
[TBL] [Abstract][Full Text] [Related]
18. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
Mishra A; Rathore AS
Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
[TBL] [Abstract][Full Text] [Related]
20. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
